Get access to our best features
Get access to our best features
Published 1 month ago

Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors

  • T-Cells were genetically modified in a lab to recognize specific proteins on brain tumor cells.
  • CAR-T cells were modified to reprogram suppressor T-cells into killer T-cells to fight the tumor.
  • The modifications made T-cells more effective in battling cancer by outsmarting its ability to hide from detection.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 46% of the sources lean Left
46% Left

To view factuality data please Upgrade to Premium


To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)